In the past, the primary approach for the treatment of endo-metriosis was represented by surgery; however, after the introduction of non-invasive diagnosis of endometriosis with the development of imaging technologies, medical treatment became the preferred approach, particularly in young patients. Hormonal drugs, by blocking menstruation, are the most effective for the treatment of endometriosis-related pain, independently of phenotype (ovarian, deep, or superficial endometriosis). Gonadotropin-releasing hormone analogs and oral antagonists act on hypothalamus-pituitary-ovary axis inducing iatrogenic menopause, thus reducing dysmenorrhea and all pain symp-toms. The side effects, such as hot flushes and bone loss, may be reduced by an add-back therapy. However, the cost in terms of women's health remains high in view of a long-term treatment. Progestins are considered the first-line treatment, highly effective, and with reduced side effects. In addition to the well-known and largely used Norethisterone acetate and Medrox-yprogesterone acetate, recently Dienogest has become one of the most used drugs in all endometriosis phenotypes for long-term treatment. Besides, Intrauterine levornogestrel or subcu-taneous etonogestrel are valid alternative for long-term treatment.

Hormonal drugs for the treatment of endometriosis / Capezzuoli, Tommaso; Rossi, Margherita; La Torre, Francesco; Vannuccini, Silvia; Petraglia, Felice. - In: CURRENT OPINION IN PHARMACOLOGY. - ISSN 1471-4892. - ELETTRONICO. - 67:(2022), pp. 102311.0-102311.0. [10.1016/j.coph.2022.102311]

Hormonal drugs for the treatment of endometriosis

Capezzuoli, Tommaso;Rossi, Margherita;La Torre, Francesco;Vannuccini, Silvia;Petraglia, Felice
2022

Abstract

In the past, the primary approach for the treatment of endo-metriosis was represented by surgery; however, after the introduction of non-invasive diagnosis of endometriosis with the development of imaging technologies, medical treatment became the preferred approach, particularly in young patients. Hormonal drugs, by blocking menstruation, are the most effective for the treatment of endometriosis-related pain, independently of phenotype (ovarian, deep, or superficial endometriosis). Gonadotropin-releasing hormone analogs and oral antagonists act on hypothalamus-pituitary-ovary axis inducing iatrogenic menopause, thus reducing dysmenorrhea and all pain symp-toms. The side effects, such as hot flushes and bone loss, may be reduced by an add-back therapy. However, the cost in terms of women's health remains high in view of a long-term treatment. Progestins are considered the first-line treatment, highly effective, and with reduced side effects. In addition to the well-known and largely used Norethisterone acetate and Medrox-yprogesterone acetate, recently Dienogest has become one of the most used drugs in all endometriosis phenotypes for long-term treatment. Besides, Intrauterine levornogestrel or subcu-taneous etonogestrel are valid alternative for long-term treatment.
2022
67
0
0
Goal 5: Gender equality
Capezzuoli, Tommaso; Rossi, Margherita; La Torre, Francesco; Vannuccini, Silvia; Petraglia, Felice
File in questo prodotto:
File Dimensione Formato  
2022_Hormonal drugs endometriosis_curr pharma.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 551.12 kB
Formato Adobe PDF
551.12 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1358253
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 10
social impact